Graphic: Shutterstock
FDA approves two gene therapies for sickle cell disease, including first that uses CRISPR
In a landmark moment for genetic medicine and sickle cell disease patients, the FDA on Friday approved not just one but two gene therapies for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.